Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Marien Gesellschaft Siegen gGmbH

Siegen, GermanyNot linked to an institution yet

5running trials
2closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Recruiting
PREFer
NCT06916416· Phase 2· Source
Not yet recruiting
Pre-Operative Treatment in REseCTable COlon CanceR
NCT06899477· Phase 3· Source
Recruiting
Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients
NCT05665140· Phase 2/3· Source
Recruiting
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
NCT05008809· Phase 3· Source
Active, not recruiting
Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
NCT03948035· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Researchers

No researcher is linked here yet.

Closed trials

Completed
CIRCULATE
NCT04089631· Phase 3· Source
Completed
HD21
NCT02661503· Phase 3· Source

Site data: EU CTIS (euclinicaltrials.eu)Updated 5 Nov 2026

Report an error

Under construction, not live – Marien Gesellschaft Siegen gGmbH: trial site – Frontlight Research